Pricing Log in Create free account

CNS Pharmaceuticals, Inc. (CNSP) vs Soligenix Inc. (SNGX)

CNS Pharmaceuticals, Inc. and Soligenix Inc. are both Biotechnology companies. CNS Pharmaceuticals, Inc. and Soligenix Inc. are of similar size ($7.9M and $7.7M). Across the 8 metrics below, CNS Pharmaceuticals, Inc. leads on 6 and Soligenix Inc. on 2.

Valuation

Metric CNSP SNGX Biotechnology median
P/E n/m n/m 8.50
P/S n/m 11.29 9.71
P/B 1.82 0.84 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.17 0.64
EV/Sales n/m (3.73) 9.21
Earnings yield (486.39%) (211.20%) (33.15%)
Free cash flow yield (40.54%) (174.60%) (25.50%)

Profitability

Metric CNSP SNGX Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (106.62%) (241.65%) (56.36%)
Return on assets (91.64%) (125.95%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CNSP SNGX Biotechnology median
Revenue growth (TTM) — (50.37%) 6.02%
EPS growth (last fiscal year) 92.34% 57.03% 30.26%
Revenue growth, 5-year CAGR — (51.88%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CNSP SNGX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.86 2.77 4.72
Net debt to EBITDA 0.45 0.67 0.96

Dividend

Metric CNSP SNGX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CNSP SNGX Biotechnology median
Market cap 7.88m 7.73m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack